The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Tyzavan
Vancomycin · VANCOMYCIN 750 mg/150mL · Injection, Solution · Intravenous · Hikma Pharmaceuticals USA Inc.
NDC 00143-9468-06 · 6 BAG in 1 CARTON / 150 mL in 1 BAG · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA211962
- TE code
- —
- Approval date
- Feb 15, 2019
- Patents / exclusivity
- 42 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 10188697 | Nov 6, 2035 |
| patent | 10039804 | Nov 6, 2035 |
| patent | 10188697 | Nov 6, 2035 |
| patent | 10188697 | Nov 6, 2035 |
| patent | 10039804 | Nov 6, 2035 |
| patent | 11517609 | Nov 6, 2035 |
| patent | 11517609 | Nov 6, 2035 |
| patent | 11517609 | Nov 6, 2035 |
| patent | 11517609 | Nov 6, 2035 |
| patent | 11517609 | Nov 6, 2035 |
| patent | 11517609 | Nov 6, 2035 |
| patent | 11517609 | Nov 6, 2035 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Vancomycin (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Hikma Pharmaceuticals USA Inc. | VANCOMYCIN 1.5 g/300mL | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | VANCOMYCIN 2 g/400mL | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | VANCOMYCIN 1.25 g/250mL | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | VANCOMYCIN 500 mg/100mL | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | VANCOMYCIN 1.75 g/350mL | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | VANCOMYCIN 750 mg/150mL | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | VANCOMYCIN 1 g/200mL | Jul 15, 2026 | Sep 2, 2026 |
| Xellia Pharmaceuticals USA LLC | VANCOMYCIN 750 mg/150mL | Jul 15, 2026 | Sep 2, 2026 |
| Xellia Pharmaceuticals USA LLC | VANCOMYCIN 1 g/200mL | Jul 15, 2026 | Sep 2, 2026 |
| Xellia Pharmaceuticals USA LLC | VANCOMYCIN 1.25 g/250mL | Jul 15, 2026 | Sep 2, 2026 |
| Xellia Pharmaceuticals USA LLC | VANCOMYCIN 1.5 g/300mL | Jul 15, 2026 | Sep 2, 2026 |
| Xellia Pharmaceuticals USA LLC | VANCOMYCIN 1.75 g/350mL | Jul 15, 2026 | Sep 2, 2026 |
| Xellia Pharmaceuticals USA LLC | VANCOMYCIN 2 g/400mL | Jul 15, 2026 | Sep 2, 2026 |
| Xellia Pharmaceuticals USA LLC | VANCOMYCIN 500 mg/100mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Tyzavan — NDC 00143-9468-06," retrieved September 3, 2026, https://drugdashboards.com/drug/00143946806.
Free to cite with attribution — see how the data is put together.